Clinical Trials
All Clinical Trials - Page 68 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT00353496Phase 3Completed
Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours
Lanreotide
- NCT00337766Phase 4Completed
Desmopressin in Cardiac Surgery
Desmopressin
- NCT00382174Phase 2Completed
Study of Thymosin Beta 4 in Patients With Pressure Ulcers
TB-500
- NCT00318422Phase 3Completed
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
Liraglutide
- NCT00318461Phase 3Completed
To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together
Liraglutide
- NCT00331851Phase 3Completed
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
Liraglutide
- NCT01518166Phase 1Completed
Effect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pH
Liraglutide
- NCT00326469Phase 2Completed
Efficacy and Safety of Lanreotide Autogel in Tumour Stabilization of Patients With Progressive Neuroendocrine Tumours
Lanreotide
- NCT01515579Phase 1Completed
Comparison of Two Liraglutide Formulations in Healthy Subjects
Liraglutide
- NCT00313001Phase 3Completed
Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.
Exenatide
- NCT00308139Phase 3Completed
Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)
Exenatide
- NCT00313183Phase 2Completed
A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes Mellitus
Pramlintide
- NCT00309283Phase 3Completed
Somatostatin in Polycystic Kidney: a Long-term Three Year Follow up Study
Octreotide
- NCT01507389Phase 1Completed
Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver Function
Liraglutide
- NCT01535027Phase 4Completed
Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal Osteoporosis
Teriparatide
- NCT00376064Phase 4Completed
Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly
Octreotide
- NCT00306748Phase 2Completed
Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation
Linaclotide
- NCT00311766Phase 2Terminated
A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
TB-500
- NCT00425256Phase 2Completed
Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD)
PT-141
- NCT00257712Phase 2Completed
SMART: Somatotrophics, Memory, and Aging Research Trial
Tesamorelin
- NCT00275262Phase 2Terminated
A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation
Gonadorelin
- NCT00294723Phase 3Terminated
To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c
Liraglutide
- NCT00254254Phase 2Completed
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes Mellitus
Exenatide
- NCT00299871Phase 2Completed
Dose Ranging Study of the GLP-1 Agonist AVE0010 in Metformin-Treated Subjects With Type 2 Diabetes Mellitus
Lixisenatide
- NCT01515592Phase 1Completed
Safety and Tolerability of Liraglutide in Healthy Japanese Male Volunteers
Liraglutide
- NCT00324363Phase 3Completed
Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin
Exenatide
- NCT00691158N/AUnknown
A Study of the Functional Magnetic Resonance Imaging Response to Leptin and Pramlintide
Pramlintide
- NCT00291772Phase 4Completed
Continuous Subcutaneous Infusion of Pramlintide and Insulin
Pramlintide
- NCT02304887N/AUnknown
The Relationship Between the Residual Renal Function and Osteoporosis Treatment
Teriparatide
- NCT00990535Phase 2Completed
High Dose Somatostatin Analogues in Neuroendocrine Tumors
Octreotide
- NCT01203306Phase 2Unknown
Bevacizumab Plus Somatostatin Analogue and Metronomic Capecitabine in Patients With Advanced Neuroendocrine Tumors
Octreotide
- NCT00274170Phase 1/Phase 2Unknown
Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache
Octreotide
- NCT00288522Phase 2Terminated
Lanreotide (Somatuline Autogel) in Thyroid-associated Ophthalmopathy Treatment
Lanreotide
- NCT00258193Phase 2Completed
Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBS
Linaclotide
- NCT00267527Phase 2Terminated
A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity
CJC-1295
- NCT00291616Phase 4Completed
Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B
Thymosin-Alpha-1
- NCT00288080Phase 3Completed
Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
Gonadorelin
- NCT01218581Phase 2/Phase 3Completed
Aromatase Inhibitors or GnRH-a for Uterine Adenomyosis
Gonadorelin
- NCT00283062Phase 3Completed
Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy
Gonadorelin
- NCT00372697Phase 3Completed
Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly
Octreotide
- NCT01511692Phase 1Completed
Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes
Liraglutide
- NCT00254800Phase 1Completed
The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females
Exenatide
- NCT00259298Phase 4Completed
Evaluation of the Effects of Teriparatide on Skeleton Images in Postmenopausal Women With Osteoporosis
Teriparatide
- NCT01267669N/ACompleted
A Trial of Somatostatin With Endoscopic Variceal Ligation (EVL) in Control of Acute Variceal Bleeding
Octreotide
- NCT00248157Phase 3Terminated
Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
Octreotide
- NCT00248131Phase 3Terminated
Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
Octreotide
- NCT00259896Phase 1Completed
In-patient Study in Patients With Type 2 Diabetes Mellitus
Exenatide
- NCT00135330Phase 3Completed
An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus
Exenatide
- NCT00241423Phase 2Completed
Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes
Exenatide
- NCT00240253Phase 4Completed
A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes
Pramlintide